Navigation Links
Experts from NYU Langone present new research at American College of Rheumatology 2013 Annual Meeting
Date:10/30/2013

Experts from NYU Langone's Department of Medicine, Division of Rheumatology presented new research and participated in expert panel discussions at the American College of Rheumatology 2013 Annual Meeting in San Diego, CA, October 26-30.

"We are thrilled for the opportunity to present important findings that may lead to new therapies for several autoimmune and rheumatic conditions," said Jill P. Buyon, MD, professor and director, Department of Medicine, Division of Rheumatology at NYU Langone Medical Center. "This meeting provides an opportunity to contribute to the growing body of knowledge regarding inflammatory disease while collaborating with other leaders in the field to ensure information sharing among clinicians and ultimately help enhance patient care."

Significant research presentations from NYU Langone rheumatologists will include:

First Stage of a Simon's Two-Stage Optimal Approach Supports Placental Transfer of Hydroxychloroquine and a Reduced Recurrence Rate of the Cardiac Manifestations of Neonatal Lupus

Presenter: Peter M. Izmirly, MD; Co-Authors: Nathalie Costedoat-Chalumeau, MD, PhD; Amit Saxena, MD; Amanda Zink; Zoey A. Smith; Deborah Freidman, MD; Jill P. Buyon, MD
Abstract: #2830
Wednesday, October 30, 2013 at 9:00A PDT

Women with anti-Ro antibodies, an antibody present in both Systemic Lupus Erythematosus (SLE) and Sjogren's Syndrome, are faced with the possibility of having a child with a permanent and sometimes fatal heart condition. Women who have had one child with this heart problem are at high risk for having a second affected child. To date, no therapies have proven effective in prevention. Data generated at NYU Langone show promise for a drug called hydroxychloroquine (HCQ), an anti-inflammatory agent, to prevent recurrent heart disease. If these findings are further substantiated, HCQ may gain widespread acceptance for use in these at risk pregnancies.

Learn More

Accounting For Parental Load and Identification of Multiple Risk Variants for Anti-Ro Congenital Heart Block Through High-Density Genotyping Of Immune-Related Loci

Presenter: Robert Clancy, PhD; Co-authors: Jill P. Buyon, MD; Nathalie Costedoat-Chalumeau, MD, PhD; Antonio Brucato, MD; Kateri Levesque, FRCP(C), FRCPC, MD; Vronique Ramoni, MD; Miranda C. Marion, MA; Mary Comeau, MA; Satria Sajuthi, MS; Paula S. Ramos, PhD; Robert P. Kimberly, MD; Timothy D. Howard, PhD; Carl D. Langefeld, PhD
Abstract: #2861
Wednesday, October 30, 2013 at 11:15A PDT

Fetuses of mothers who are otherwise healthy, or suffer from a rheumatic disease but have autoantibodies to SSA/Ro, are at risk for having permanent heart damage which may be fatal or require lifelong pacing. Prior genetic studies, as well as bench research, highlight injury secondary to an excessive immune response. The goal of this study was to determine the role of the genetic composition of the fetus while accounting for the maternal autoimmune disease load. An immunochip platform and association study were performed using subjects from an international cohort of US, France and Italy. The results yielded a panel of confirmed and newly identified risk genes. These genetic building blocks represent important milestones towards clarifying the mechanism by which these autoantibodies cause cardiac scarring a critical component to treatment/prevention strategies.

Learn More

For more information on abstracts, presentations and seminars, visit American College of Rheumatology Sessions 2013.


'/>"/>

Contact: Craig Andrews
craig.andrews@nyumc.org
212-404-3511
NYU Langone Medical Center / New York University School of Medicine
Source:Eurekalert

Related biology news :

1. Worlds leading coral experts to gather in Australia
2. Smell and taste experts to discuss new discoveries
3. Coral reef experts to present latest coral reef science during July symposium
4. Divide the Antarctic to protect native species, propose experts
5. World experts meet in Edinburgh to consider how life experiences impact on our genes
6. Major migration of bird experts flock to Vancouver
7. Experts propose cyber war on cancer
8. World experts enlist to help Malaysia mitigate problem of poorer nutrition as incomes rise
9. The IPCC Report on Climate Change - Swedish professor Thomas Sterner selected as 1 of the experts
10. Leader experts in neurorehabilitation gather in Toledo, Spain
11. Preserve the services of mangroves -- Earths invaluable coastal forests, experts urge
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2017)... SANTA MONICA, Calif. , April 13, 2017 /PRNewswire/ ... New York will feature emerging and ... Innovation Summits. Both Innovation Summits will run alongside the ... variety of speaker sessions, panels and demonstrations focused on ... east coast,s largest advanced design and manufacturing event will ...
(Date:4/11/2017)... , Apr. 11, 2017 Research and ... Market 2017-2021" report to their offering. ... The global eye tracking market to grow at a ... report, Global Eye Tracking Market 2017-2021, has been prepared based on ... covers the market landscape and its growth prospects over the coming ...
(Date:4/6/2017)... -- Forecasts by Product Type (EAC), Biometrics, ... (Transportation & Logistics, Government & Public Sector, Utilities / ... Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), Hospitality ... looking for a definitive report on the $27.9bn Access ... ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... CA (PRWEB) , ... October ... ... (https://www.onramp.bio/ ) has launched Rosalind™, the first-ever genomics analysis platform specifically designed ... bioinformatics complexity. Named in honor of pioneering researcher Rosalind Franklin, who made ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... pathology, announced today it will be hosting a Webinar titled, “Pathology is going ... Pathology Associates , on digital pathology adoption best practices and how Proscia improves ...
(Date:10/11/2017)... Bay, Florida (PRWEB) , ... October 11, 2017 ... ... and Drug Administration (FDA) has granted orphan drug designation to SBT-100, its novel ... (sdAb) for the treatment of osteosarcoma. SBT-100 is able to cross the cell ...
(Date:10/10/2017)... Oct. 10, 2017 International research firm Parks Associates ... speak at the TMA 2017 Annual Meeting , October 11 in ... the residential home security market and how smart safety and security products ... Parks Associates: Smart ... "The residential security market ...
Breaking Biology Technology: